Previous Article | Next Article 
Journal of Virology, January 1999, p. 362-367, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Dynamics of Human Immunodeficiency Virus Type 1 Replication in Vertically Infected Infants
Katherine
Luzuriaga,1,*
Hulin
Wu,2
Margaret
McManus,1
Paula
Britto,2
William
Borkowsky,3
Sandra
Burchett,4
Betsy
Smith,5
Lynne
Mofenson,6
John L.
Sullivan,1 and
the PACTG
356 Investigators
Department of Pediatrics, Program in
Molecular Medicine, University of Massachusetts Medical School,
Worcester,1 and
Statistical and Data
Analysis Center, Harvard School of Public
Health,2 and
Boston Children's
Hospital,4 Boston, Massachusetts;
Department of Pediatrics, New York University, New York, New
York3; and
Division of AIDS,
National Institute of Allergy and Infectious
Diseases,5 and
Pediatric, Adolescent
and Maternal AIDS Branch, National Institute of Child Health & Human Development,6 National Institutes of
Health, Bethesda, Maryland
Received 24 June 1998/Accepted 8 October 1998
Plasma human immunodeficiency virus type 1 (HIV-1) turnover and
kinetics were studied in children aged 15 days to 2 years following the
initiation of a triple antiretroviral drug regimen consisting of
zidovudine, lamivudine, and nevirapine. HIV-1 turnover was at
least as rapid as that previously described in adults; turnover rates
were more rapid in infants and children aged 3 months to 2 years than
in infants less than 3 months of age. These data confirm the central
role of HIV-1 replication in the pathogenesis of vertical HIV-1
infection and reinforce the importance of early, potent
combination therapies for the long-term control of HIV-1 replication.
*
Corresponding author. Mailing address: Department of
Pediatrics, Program in Molecular Medicine, Room 318, Biotech 2, 373 Plantation St., Worcester, MA 01605. Phone: (508) 856-6282. Fax: (508)
856-5500. E-mail: katherine.luzuriaga{at}ummed.edu.
PACTG 356 Investigators who contributed to this study include
George Johnson (Medical University of South Carolina, Charleston), Hannah Gay (University of Mississippi Medical Center, Jackson), Stuart
Starr (Children's Hospital, Philadelphia, Philadelphia, Pa.),
Diane Wara (University of California, San Francisco, San Francisco),
Yvonne Bryson (University of California, Los Angeles, Los Angeles),
Colleen Cunningham (SUNY Syracuse, Syracuse, N.Y.), Ross McKinney,
Jr. (Duke University Medical Center, Durham, N.C.), and Barbara
Stechenberg (Baystate Medical Center, Springfield, Mass.).
Journal of Virology, January 1999, p. 362-367, Vol. 73, No. 1
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Lohman, B. L., Slyker, J. A., Richardson, B. A., Farquhar, C., Mabuka, J. M., Crudder, C., Dong, T., Obimbo, E., Mbori-Ngacha, D., Overbaugh, J., Rowland-Jones, S., John-Stewart, G.
(2005). Longitudinal Assessment of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Gamma Interferon Responses during the First Year of Life in HIV-1-Infected Infants. J. Virol.
79: 8121-8130
[Abstract]
[Full Text]
-
Berk, D. R., Falkovitz-Halpern, M. S., Hill, D. W., Albin, C., Arrieta, A., Bork, J. M., Cohan, D., Nilson, B., Petru, A., Ruiz, J., Weintrub, P. S., Wenman, W., Maldonado, Y. A., for the California Pediatric HIV Study Group,
(2005). Temporal Trends in Early Clinical Manifestations of Perinatal HIV Infection in a Population-Based Cohort. JAMA
293: 2221-2231
[Abstract]
[Full Text]
-
Wu, H.
(2005). Statistical methods for HIV dynamic studies in AIDS clinical trials. Stat Methods Med Res
14: 171-192
[Abstract]
-
Plipat, N., Ruan, P. K., Fenton, T., Yogev, R.
(2004). Rapid Human Immunodeficiency Virus Decay in Highly Active Antiretroviral Therapy (HAART)-Experienced Children after Starting Mega-HAART. J. Virol.
78: 11272-11275
[Abstract]
[Full Text]
-
Luzuriaga, K., McManus, M., Mofenson, L., Britto, P., Graham, B., Sullivan, J. L., the PACTG 356 Investigators,
(2004). A Trial of Three Antiretroviral Regimens in HIV-1-Infected Children. NEJM
350: 2471-2480
[Abstract]
[Full Text]
-
Persaud, D., Siberry, G. K., Ahonkhai, A., Kajdas, J., Monie, D., Hutton, N., Watson, D. C., Quinn, T. C., Ray, S. C., Siliciano, R. F.
(2004). Continued Production of Drug-Sensitive Human Immunodeficiency Virus Type 1 in Children on Combination Antiretroviral Therapy Who Have Undetectable Viral Loads. J. Virol.
78: 968-979
[Abstract]
[Full Text]
-
Hermankova, M., Ray, S. C., Ruff, C., Powell-Davis, M., Ingersoll, R., D'Aquila, R. T., Quinn, T. C., Siliciano, J. D., Siliciano, R. F., Persaud, D.
(2001). HIV-1 Drug Resistance Profiles in Children and Adults With Viral Load of <50 Copies/mL Receiving Combination Therapy. JAMA
286: 196-207
[Abstract]
[Full Text]
-
Luzuriaga, K., McManus, M., Catalina, M., Mayack, S., Sharkey, M., Stevenson, M.
(2000). Early Therapy of Vertical Human Immunodeficiency Virus Type 1 (HIV-1) Infection: Control of Viral Replication and Absence of Persistent HIV-1-Specific Immune Responses. J. Virol.
74: 6984-6991
[Abstract]
[Full Text]